Skip to main content

Table 1 Single factor analysis of DPN selection variables

From: Study on risk factors of diabetic peripheral neuropathy and establishment of a prediction model by machine learning

Characteristic

NDPN

DPN

Pvaluea

Age(years)

56·0(46·0–65·0)

64·50(55·0–72·0)

< 0·001

Alanine aminotransferase (U/L)

20·0(14·0–22·0)

17·0(13·0–24·0)

< 0·001

Albumin(g/L)

41·9(39·6–43·8)

40·8(38·4-–43·3)

< 0·001

Total bilirubin(µmol/L)

10·4(7·9–13·8)

9·9(7·3–13·0)

0·005

Urea(mmol/L)

5·3(4·4–6·4)

5·8(4·7–7·1)

< 0·001

Creatinine(µmol/L)

66·6(56·0–77·8)

66·1(56·0–80·1)

0·319

Uric acid(µmol/L)

317·0(269·0–393·0)

318·0(262·0–377·0)

0·231

Total Cholesterol(mmol/L)

4·9(3·9–5·3)

4·4(3·6–5·3)

0·012

Glycated hemoglobin(mg/dl)

8·0(6·8–9·6)

8·8(7·3–10·5)

< 0·001

Activated partial thromboplastin time(s)

36·0(33·4–38·9)

35·0(32·8–37·6)

< 0·001

Urine protein quantity(mg/L)

39·0(24·0–75·0)

61·0(32·0–146·0)

< 0·001

24 h urine protein quantity(mg/24 h)

80·5(44·5–128·5)

109·0(60·0–263·0)

< 0·001

Diabetes duration(years)

5·0(2·0–11·0)

10·0(4·0–18·0)

< 0·001

C2/C0

3·3(2·4–4·6)

2·9(1·9–4·1)

< 0·001

NLR

1·8(1·3–2·6)

2·1(1·6–3·0)

< 0·001

HOMA-IR

2·7(1·6–4·4)

3·1(1·7–5·4)

0·011

  1. aStatistics: Mann-Whitney U Test for continuous variable comparisons; P < 0.05 are in bold